Banco Santander SA ADR

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$6.43-$13.24
Market Cap
$175.8B
Shares Short
81M

Financials

See more
Revenue (12 Mos)
$46.8B
Revenue Growth (YoY)
-6.4%
Gross Profit (12 Mos)
$46.8B
Diluted EPS
$0.97

News

See more

Yahoo Finance • yesterday

Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)

Yahoo Finance • yesterday

Communiqué de presse : Dupixent de Sanofi et Regeneron approuvé dans l'UE comme premier médicament ciblé contre l'urticaire chronique spontanée chez les jeunes enfants

Yahoo Finance • yesterday

Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria

Yahoo Finance • 4 days ago

Atopic Dermatitis (7MM) Drug Market Forecast and Analysis Report 2023-2033: Opportunities Remain for the Treatment of AD, Novel Systemic Therapies Dominate the Late-stage Pipeline

About

CEO
Mr. Hector Blas Grisi Checa
CFO
Mr. Jose Antonio Garcia-Cantera
Address
Santander Group City, Madrid, Spain, 28660
Sector
Financial Services
Industry
Banks - Diversified
Full-Time Employees
192,241